SOLIGENIX, INC. Deferred Income Tax Assets, Net
SOLIGENIX, INC. (SNGX) had Deferred Income Tax Assets, Net of $14.00 million as of 2018-09-30, per its 10-Q filed 2018-11-09.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:DeferredIncomeTaxAssetsNet · last filed 2019-03-26
- 2018-09-30: Deferred Income Tax Assets, Net $14.00M.
- 2018-06-30: Deferred Income Tax Assets, Net $14.00M.
- 2018-03-31: Deferred Income Tax Assets, Net $14.00M.
- 2017-12-31: Deferred Income Tax Assets, Net $14.00M.
| Period end | Deferred Income Tax Assets, Net |
|---|---|
| 2018-09-30 | $14.00M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $14.00M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $14.00M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $14.00M 10-K · filed 2019-03-26 |
| 2017-12-22 | $14.00M 10-K · filed 2018-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |